Founded in 1963, AET, the Hamburg company named after its founder Alfred E. Tiefenbacher, has been growing successfully for over 45 years in the market for active pharmaceuticals.

Representing active pharmaceutical ingredient (API) producers has provided the foundation for AET’s growth into a pharmaceutical company, capable of independently developing, registering and supplying finished dosage form (FDF) generic pharmaceuticals to marketing organisations internationally. AET enjoys an industry leading reputation for technical excellence and service.